A Type 1 diabetes genetic risk score can identify patients with glutamic acid decarboxylase (GAD) antibody-positive Type 2 diabetes with and without rapid progression to insulin therapy

A. L. Grubb; L. A. Donnelly; R. C. Slieker; T. J. McDonald; F. Rutters; L. M. 't Hart; E. R. Pearson; A. T. Hattersley; B. M. Shields; A. G. Jones; R. A. Oram; M. N. Weedon

A Type 1 diabetes genetic risk score can identify patients with glutamic acid decarboxylase (GAD) antibody-positive Type 2 diabetes with and without rapid progression to insulin therapy

A. L. Grubb, L. A. Donnelly, R. C. Slieker, T. J. McDonald, F. Rutters, L. M. 't Hart, E. R. Pearson, A. T. Hattersley, B. M. Shields, A. G. Jones, R. A. Oram, M. N. Weedon

Research output: Contribution to journal › Meeting Abstract › Academic

Original language	English
Pages (from-to)	204-204
Journal	Diabetic Medicine
Volume	35
Publication status	Published - Mar 2018

Cite this

Grubb, A. L., Donnelly, L. A., Slieker, R. C., McDonald, T. J., Rutters, F., 't Hart, L. M., Pearson, E. R., Hattersley, A. T., Shields, B. M., Jones, A. G., Oram, R. A., & Weedon, M. N. (2018). A Type 1 diabetes genetic risk score can identify patients with glutamic acid decarboxylase (GAD) antibody-positive Type 2 diabetes with and without rapid progression to insulin therapy. Diabetic Medicine, 35, 204-204.

@article{1dbf09c40f0544bc8e561fc714c33f40,

title = "A Type 1 diabetes genetic risk score can identify patients with glutamic acid decarboxylase (GAD) antibody-positive Type 2 diabetes with and without rapid progression to insulin therapy",

author = "Grubb, {A. L.} and Donnelly, {L. A.} and Slieker, {R. C.} and McDonald, {T. J.} and F. Rutters and {'t Hart}, {L. M.} and Pearson, {E. R.} and Hattersley, {A. T.} and Shields, {B. M.} and Jones, {A. G.} and Oram, {R. A.} and Weedon, {M. N.}",

year = "2018",

month = mar,

language = "English",

volume = "35",

pages = "204--204",

journal = "Diabetic Medicine",

issn = "0742-3071",

publisher = "Wiley-Blackwell",

}

Grubb, AL, Donnelly, LA, Slieker, RC, McDonald, TJ, Rutters, F , 't Hart, LM, Pearson, ER, Hattersley, AT, Shields, BM, Jones, AG, Oram, RA & Weedon, MN 2018, 'A Type 1 diabetes genetic risk score can identify patients with glutamic acid decarboxylase (GAD) antibody-positive Type 2 diabetes with and without rapid progression to insulin therapy', Diabetic Medicine, vol. 35, pp. 204-204.

TY - JOUR

T1 - A Type 1 diabetes genetic risk score can identify patients with glutamic acid decarboxylase (GAD) antibody-positive Type 2 diabetes with and without rapid progression to insulin therapy

AU - Grubb, A. L.

AU - Donnelly, L. A.

AU - Slieker, R. C.

AU - McDonald, T. J.

AU - Rutters, F.

AU - 't Hart, L. M.

AU - Pearson, E. R.

AU - Hattersley, A. T.

AU - Shields, B. M.

AU - Jones, A. G.

AU - Oram, R. A.

AU - Weedon, M. N.

PY - 2018/3

Y1 - 2018/3

M3 - Meeting Abstract

VL - 35

SP - 204

EP - 204

JO - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

ER -